David J Sundin

age ~61

from Temecula, CA

Get Report

Also known as:

David John Sundin
David Sarah Sundin
Dave J Sundin
David Dundin

Connected to:

David Sundin Phones & Addresses

Temecula, CA
2301 Foothill Dr, Antioch, CA 94509
265 Camelback Rd #316, Pleasant Hill, CA 94523
Lancaster, CA
87 Behr Ave, San Francisco, CA 94131
5423 E Creek Ct, Antioch, CA 94531

Us Patents

Methods And Compositions For Treatment Of Otitis Media
view source
US Patent:

20040175383, Sep 9, 2004
Filed:

Dec 8, 2003
Appl. No.:

10/731375
Inventors:

Philip Barr - Oakland CA, US
Philip Pemberton - San Mateo CA, US
Patrick Antonelli - Gainesville FL, US
Gregory Schultz - Gainesville FL, US
David Sundin - Antioch CA, US
International Classification:

A61K039/395
A61K031/56
US Classification:

424/146100, 514/171000, 424/046000
Abstract:

The invention is directed to the treatment of otitis media by administration of protease inhibitors. In some embodiments, the protease inhibitors are alpha one-antitrypsin and/or ilomastat.

Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors
view source
US Patent:

20080095806, Apr 24, 2008
Filed:

Nov 20, 2003
Appl. No.:

10/535609
Inventors:

Ian C. Bathurst - Alameda CA, US
Philip A. Pemberton - Alameda CA, US
David J. Sundin - Alameda CA, US
James W. Mayhew - Petaluma CA, US
Arturo J. Angel - Petaluma CA, US
Philip J. Barr - Alameda CA, US
International Classification:

A61K 38/55
A61K 9/00
US Classification:

424400, 514 12
Abstract:

Compositions containing a protease inhibitor and methods of use and production are described. The compositions contain an effective amount of a protease inhibitor in a carrier or diluent and are used for the treatment of inflammatory or hyperproliferic mucocutaneous disorders. The carrier or diluent is preferably a gelling agent, and the composition is a topical gel formulation containing alpha -antitrypsin in an aqueous liquid or viscous gel formulation.

Resumes

Coo At Avatar Energy

view source

Position:

COO at Avatar Energy

Location:

United States

Industry:

Pharmaceuticals

Work:

Avatar Energy since Nov 2009
COO
Adamas Pharmaceuticals, Inc. Oct 2009 - Dec 2009
Consultant
Adamas Pharmaceuticals, Inc. Dec 2008 - Oct 2009
Sr Director, Global Clinical Operations
Cerus Mar 2006 - Dec 2008
Director Clinical Research/Medical Affairs
Arriva Pharmaceuticals Aug 2000 - Mar 2006
Sr Director, Clinical Research and Operations

Education:

University of California, San Francisco 1985 - 1989
Pharm.D. University of California, Los Angeles 1981 - 1985
BS, Microbiology

Skills:

Biotechnology